[144] Cardinal Health, Inc. SEC Filing
Cardinal Health (CAH) Form 144 notice reports a proposed sale of 38,078 common shares through Merrill Lynch on the NYSE with an aggregate market value of $5,666,934.00, and approximately 238,793,647 shares outstanding. The securities to be sold were acquired mostly through performance unit vesting and restricted stock vesting on dates between November 15, 2022 and August 15, 2025, with specific lots of 18,500; 5,160; 5,300; 4,955; and 4,163 shares listed. The filer certifies no undisclosed material adverse information and provides a notice date and signature block as required by Rule 144.
Cardinal Health (CAH) nel modulo 144 dichiara la proposta vendita di 38.078 azioni ordinarie tramite Merrill Lynch sul NYSE, per un valore complessivo di $5.666.934,00, con circa 238.793.647 azioni in circolazione. I titoli oggetto della vendita sono stati acquisiti principalmente tramite il vesting di performance unit e il vesting di restricted stock in date comprese tra il 15 novembre 2022 e il 15 agosto 2025; sono indicati lotti specifici da 18.500; 5.160; 5.300; 4.955; e 4.163 azioni. Il dichiarante certifica l'assenza di informazioni materiali sfavorevoli non divulgate e fornisce la data di notifica e la firma richieste dalla Regola 144.
Cardinal Health (CAH) en el formulario 144 informa sobre la propuesta de venta de 38.078 acciones ordinarias a trav茅s de Merrill Lynch en la NYSE, por un valor agregado de $5.666.934,00, y aproximadamente 238.793.647 acciones en circulaci贸n. Los valores a vender se adquirieron mayoritariamente mediante el vesting de unidades por desempe帽o y el vesting de acciones restringidas en fechas entre el 15 de noviembre de 2022 y el 15 de agosto de 2025, con lotes espec铆ficos de 18.500; 5.160; 5.300; 4.955; y 4.163 acciones. El declarante certifica que no existe informaci贸n material adversa no divulgada y proporciona la fecha de notificaci贸n y el bloque de firma exigidos por la Regla 144.
Cardinal Health (CAH)臧� Form 144鞐愳劀 NYSE鞚� Merrill Lynch毳� 韱淀暣 38,078欤� 氤错喌欤� 毵り皝鞚� 鞝滌晥頄堨潓鞚� 氤搓碃頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $5,666,934.00鞚搓碃 氚滍枆 欤检嫕 靾橂姅 鞎� 238,793,647欤检瀰雼堧嫟. 毵る弰 雽�靸� 歃濌秾鞚� 雽�攵�攵� 靹标臣 雼渼 氩犾姢韺� 氚� 鞝滍暅欤� 氩犾姢韺�鞚� 韱淀暣 2022雲� 11鞗� 15鞚茧秬韯� 2025雲� 8鞗� 15鞚� 靷澊鞐� 旆摑霅橃棃鞙茧┌, 18,500; 5,160; 5,300; 4,955; 4,163欤检潣 甑泊鞝� 搿滍姼臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橁碃, 攴滌箼 144臧� 鞖旉惮頃橂姅 韱奠鞚缄臣 靹滊獏霝�鞚� 鞝滉车頃╇媹雼�.
Cardinal Health (CAH) indique dans le formulaire 144 une vente propos茅e de 38 078 actions ordinaires via Merrill Lynch sur le NYSE, pour une valeur totale de 5 666 934,00 $, et environ 238 793 647 actions en circulation. Les titres 脿 vendre ont 茅t茅 acquis principalement par le vesting d'unit茅s de performance et le vesting d'actions restreintes entre le 15 novembre 2022 et le 15 ao没t 2025, avec des lots sp茅cifiques de 18 500; 5 160; 5 300; 4 955; et 4 163 actions. Le d茅clarant certifie qu'il n'existe pas d'informations d茅favorables mat茅rielles non divulgu茅es et fournit la date de notification ainsi que le bloc de signature exig茅s par la r猫gle 144.
Cardinal Health (CAH) meldet im Formular 144 einen geplanten Verkauf von 38.078 Stammaktien 眉ber Merrill Lynch an der NYSE mit einem Gesamtmarktwert von $5.666.934,00 und rund 238.793.647 ausstehenden Aktien. Die zu verkaufenden Wertpapiere wurden 眉berwiegend durch Vesting von Performance-Einheiten und Vesting von Restricted Stock an Daten zwischen dem 15. November 2022 und dem 15. August 2025 erworben; aufgef眉hrt sind bestimmte Lose von 18.500; 5.160; 5.300; 4.955; und 4.163 Aktien. Der Einreicher best盲tigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und stellt das f眉r Regel 144 erforderliche Benachrichtigungsdatum sowie das Unterschriftsfeld bereit.
- Filing compliance: Notice provides required Rule 144 details including broker, acquisition dates, and certification regarding material information
- Transparency of provenance: Acquisition history shows shares originate from performance units and restricted stock vesting, not open-market purchases
- Insider sale size: Proposed sale of 38,078 shares valued at $5,666,934 could be viewed as a significant insider liquidity event
- Concentration of vested awards: Multiple recent vesting events in 2025 aggregate into the block proposed for sale, reducing insider stake from those awards
Insights
TL;DR: Insider filing notifies sale of 38,078 CAH shares valued at $5.67M; procedurally compliant but represents an insider liquidity event.
The Form 144 documents a proposed sale under Rule 144 of 38,078 Cardinal Health common shares via Merrill Lynch on the NYSE, totaling $5,666,934. The lots originate from performance unit and restricted stock vesting between 2022 and 2025. The filing contains the required certification that no material non-public information is known to the seller. This is a routine disclosure of an insider-liquidity transaction and provides transparency on the timing, broker, and acquisition history for the shares to be sold.
TL;DR: Filing meets Rule 144 disclosure requirements; highlights multiple vesting events aggregated for sale under the rule.
The notice identifies multiple vested equity awards aggregated for sale and specifies the broker and intended sale date of 08/19/2025. The document includes the standard representation regarding lack of undisclosed material adverse information. From a governance perspective, the filing indicates the insider is following required procedural steps and documenting the provenance of shares through granted award vesting dates.
Cardinal Health (CAH) nel modulo 144 dichiara la proposta vendita di 38.078 azioni ordinarie tramite Merrill Lynch sul NYSE, per un valore complessivo di $5.666.934,00, con circa 238.793.647 azioni in circolazione. I titoli oggetto della vendita sono stati acquisiti principalmente tramite il vesting di performance unit e il vesting di restricted stock in date comprese tra il 15 novembre 2022 e il 15 agosto 2025; sono indicati lotti specifici da 18.500; 5.160; 5.300; 4.955; e 4.163 azioni. Il dichiarante certifica l'assenza di informazioni materiali sfavorevoli non divulgate e fornisce la data di notifica e la firma richieste dalla Regola 144.
Cardinal Health (CAH) en el formulario 144 informa sobre la propuesta de venta de 38.078 acciones ordinarias a trav茅s de Merrill Lynch en la NYSE, por un valor agregado de $5.666.934,00, y aproximadamente 238.793.647 acciones en circulaci贸n. Los valores a vender se adquirieron mayoritariamente mediante el vesting de unidades por desempe帽o y el vesting de acciones restringidas en fechas entre el 15 de noviembre de 2022 y el 15 de agosto de 2025, con lotes espec铆ficos de 18.500; 5.160; 5.300; 4.955; y 4.163 acciones. El declarante certifica que no existe informaci贸n material adversa no divulgada y proporciona la fecha de notificaci贸n y el bloque de firma exigidos por la Regla 144.
Cardinal Health (CAH)臧� Form 144鞐愳劀 NYSE鞚� Merrill Lynch毳� 韱淀暣 38,078欤� 氤错喌欤� 毵り皝鞚� 鞝滌晥頄堨潓鞚� 氤搓碃頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $5,666,934.00鞚搓碃 氚滍枆 欤检嫕 靾橂姅 鞎� 238,793,647欤检瀰雼堧嫟. 毵る弰 雽�靸� 歃濌秾鞚� 雽�攵�攵� 靹标臣 雼渼 氩犾姢韺� 氚� 鞝滍暅欤� 氩犾姢韺�鞚� 韱淀暣 2022雲� 11鞗� 15鞚茧秬韯� 2025雲� 8鞗� 15鞚� 靷澊鞐� 旆摑霅橃棃鞙茧┌, 18,500; 5,160; 5,300; 4,955; 4,163欤检潣 甑泊鞝� 搿滍姼臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橁碃, 攴滌箼 144臧� 鞖旉惮頃橂姅 韱奠鞚缄臣 靹滊獏霝�鞚� 鞝滉车頃╇媹雼�.
Cardinal Health (CAH) indique dans le formulaire 144 une vente propos茅e de 38 078 actions ordinaires via Merrill Lynch sur le NYSE, pour une valeur totale de 5 666 934,00 $, et environ 238 793 647 actions en circulation. Les titres 脿 vendre ont 茅t茅 acquis principalement par le vesting d'unit茅s de performance et le vesting d'actions restreintes entre le 15 novembre 2022 et le 15 ao没t 2025, avec des lots sp茅cifiques de 18 500; 5 160; 5 300; 4 955; et 4 163 actions. Le d茅clarant certifie qu'il n'existe pas d'informations d茅favorables mat茅rielles non divulgu茅es et fournit la date de notification ainsi que le bloc de signature exig茅s par la r猫gle 144.
Cardinal Health (CAH) meldet im Formular 144 einen geplanten Verkauf von 38.078 Stammaktien 眉ber Merrill Lynch an der NYSE mit einem Gesamtmarktwert von $5.666.934,00 und rund 238.793.647 ausstehenden Aktien. Die zu verkaufenden Wertpapiere wurden 眉berwiegend durch Vesting von Performance-Einheiten und Vesting von Restricted Stock an Daten zwischen dem 15. November 2022 und dem 15. August 2025 erworben; aufgef眉hrt sind bestimmte Lose von 18.500; 5.160; 5.300; 4.955; und 4.163 Aktien. Der Einreicher best盲tigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und stellt das f眉r Regel 144 erforderliche Benachrichtigungsdatum sowie das Unterschriftsfeld bereit.
FAQ
What does the Form 144 for Cardinal Health (CAH) report?
When is the approximate sale date listed on the CAH Form 144?
How were the shares to be sold acquired according to the filing?
Who is the broker named in the Form 144 for CAH?
Does the filing state whether the seller knows any material non-public information?
